본문으로 건너뛰기
← 뒤로

The evolving landscape of brain metastasis: volume II.

1/5 보강
Trends in cancer 📖 저널 OA 21.3% 2024: 1/1 OA 2025: 2/11 OA 2026: 7/35 OA 2024~2026 2026 Vol.12(2) p. 116-146
Retraction 확인
출처

Valiente M, Anders C, Boire A, Izar B, Kotecki N, Malladi S, Massagué J, Moss NS, Neman J, Preusser M, Schagen S, Siegel PM, Tawbi H, Venkataramani V, Winkler F, Zadeh G, Joyce JA

📝 환자 설명용 한 줄

Brain metastasis (BrM) represents the most common intracranial malignancy, arising in up to 30% of all adult cancer patients and contributing significantly to cancer-related morbidity and mortality.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Valiente M, Anders C, et al. (2026). The evolving landscape of brain metastasis: volume II.. Trends in cancer, 12(2), 116-146. https://doi.org/10.1016/j.trecan.2025.11.007
MLA Valiente M, et al.. "The evolving landscape of brain metastasis: volume II.." Trends in cancer, vol. 12, no. 2, 2026, pp. 116-146.
PMID 41339184 ↗

Abstract

Brain metastasis (BrM) represents the most common intracranial malignancy, arising in up to 30% of all adult cancer patients and contributing significantly to cancer-related morbidity and mortality. BrM is now recognized as a biologically distinct condition with unique mechanisms of organotropism, colonization, and therapeutic vulnerability. We highlight recent progress in omic and spatial profiling, which has revealed key drivers of brain tropism. These findings have reshaped therapeutic strategies, leading to clinical trials that specifically address central nervous system (CNS) involvement. Emerging approaches now include efforts to prevent brain relapse. Preclinical models increasingly provide sophisticated platforms to evaluate next-generation therapies. Collectively, these advances are transforming the clinical landscape, offering new hope for the prevention and management of BrM through precision medicine and integrated therapeutic strategies.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반